newsfilter
← Latest News
ACCESS Newswire·

enVVeno Medical to Present in the Webull Corporate Connect Webinar Series

  • enVVeno Medical (NASDAQ: NVNO) will present in the Webull Corporate Connect Webinar Series on Wednesday, June 24, 2026, at 2:00 PM ET.
  • CEO Rob Berman will discuss the company's mission to treat deep venous disease, the unmet need for severe Deep Venous Insufficiency (DVI), FDA IDE approval for the enVVe System, plans for the first U.S. pivotal trial of a non-surgical replacement venous valve.
  • The presentation is scheduled for 20 minutes (2:00-2:20 PM ET) on June 24, 2026.
  • enVVeno is developing the enVVe system, a first-in-class transcatheter device designed as a one-way valve to help blood flow from the leg to the heart.
  • The enVVe procedure is performed under light sedation without requiring an overnight hospital stay.
  • Webull operates a digital investment platform serving over 27 million users globally across 16 markets.
  • Investor contact is Jenene Thomas at JTC Team, LLC via NVNO@jtcir.com or (908) 824-0775.